NB-UVB phototherapy may restore adalimumab efficacy in chronic plaque psoriasis after treatment failure. Learn more about ...

Around 125 million people worldwide have psoriasis, the skin condition that causes flaky patches on the surface to form as scales. In the UK, the NHS estimates that two in 100 people suffer, with ...

Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that ...

Psoriasis symptoms can feel like a dark cloud hovering above your head. They’re pesky, sometimes even painful, making everyday life more difficult. Scalp psoriasis is a skin condition that causes the ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Should you see ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.

With cannabidiol (CBD) becoming increasingly available, many are wondering about its utility in treating various conditions. Psoriasis is one such condition. But does it really work? Psoriasis is an ...

A large US claims analysis links out-of-pocket medication costs with adherence and discontinuation patterns among patients ...

Psoriasis can be a tricky illness to treat without help from doctors and other medical professionals. It’s a lifelong skin and immune system disease that also carries a chance of forming other health ...

The clinical-stage biotechnology company is seeking regulatory clearance to begin clinical trials of CYPS317, an allogeneic ...